전임상용 분리 장기 관류 시스템 시장(2026-2030년)

The global preclinical isolated organ perfusion system market is forecasted to grow by USD 177.1 mn during 2025-2030, accelerating at a CAGR of 5.1% during the forecast period. The report on the global preclinical isolated organ perfusion system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing complexity in drug discovery and shift toward ex vivo validation, rising demand for advanced organ preservation and transplantation research, strategic integration of ai and real-time hemodynamic monitoring.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global preclinical isolated organ perfusion system market is segmented as below:

By Type

• Hardware
• Software and services

By Product

• Isolated heart perfusion systems
• Isolated abdominal organ perfusion systems
• Isolated lung perfusion systems
• Others

By End-User

• Pharmaceutical and biotechnology companies
• Contract research organizations (CROS)
• Academic and government research institutes
• Hospitals and transplant centers
• Preclinical research laboratories

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai for real-time hemodynamic monitoring and predictive analytics as one of the prime reasons driving the global preclinical isolated organ perfusion system market growth during the next few years. Also, convergence of normothermic perfusion and ex-vivo organ reconditioning platforms and adoption of modular and scalable architectures for multi-organ and micro-perfusion studies will lead to sizable demand in the market.

The report on the global preclinical isolated organ perfusion system market covers the following areas:

• Global preclinical isolated organ perfusion system market sizing
• Global preclinical isolated organ perfusion system market forecast
• Global preclinical isolated organ perfusion system market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global preclinical isolated organ perfusion system market vendors that include ADInstruments Pty Ltd., ALA Scientific Instruments Inc., Bridge to Life Ltd., emka TECHNOLOGIES, Hugo Sachs Elektronik GmbH, MDE GmbH, OrganOx Ltd., TransMedics Inc., World Precision Instruments. Also, the global preclinical isolated organ perfusion system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Preclinical Isolated Organ Perfusion System Market 2020 - 2024
  • Historic Market Size - Data Table on Global Preclinical Isolated Organ Perfusion System Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Preclinical Isolated Organ Perfusion System Market
• 6.2 Impact of geopolitical conflicts on Global Preclinical Isolated Organ Perfusion System Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Hardware - Market size and forecast 2025-2030
• 8.4 Software and services - Market size and forecast 2025-2030
• 8.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Isolated heart perfusion systems - Market size and forecast 2025-2030
• 9.4 Isolated abdominal organ perfusion systems - Market size and forecast 2025-2030
• 9.5 Isolated lung perfusion systems - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
• 10.4 Contract research organizations (CROs) - Market size and forecast 2025-2030
• 10.5 Academic and government research institutes - Market size and forecast 2025-2030
• 10.6 Hospitals and transplant centers - Market size and forecast 2025-2030
• 10.7 Preclinical research laboratories - Market size and forecast 2025-2030
• 10.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.2 Brazil - Market size and forecast 2025-2030
  • 12.6.3 Australia - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Israel - Market size and forecast 2025-2030
  • 12.6.7 Turkey - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing complexity in drug discovery and shift toward ex vivo validation
  • Rising demand for advanced organ preservation and transplantation research
  • Strategic integration of AI and real-time hemodynamic monitoring
• 13.2 Market challenges
  • High capital expenditure and lifecycle costs of advanced perfusion infrastructure
  • Technological competition from new approach methodologies and microfluidic platforms
  • Technical complexity in achieving multi-day viability and physiological realism
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of AI for real-time hemodynamic monitoring and predictive analytics
  • Convergence of normothermic perfusion and ex-vivo organ reconditioning platforms
  • Adoption of modular and scalable architectures for multi-organ and micro-perfusion studies

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 ADInstruments Pty Ltd.
  • ADInstruments Pty Ltd. - Overview
  • ADInstruments Pty Ltd. - Product / Service
  • ADInstruments Pty Ltd. - Key offerings
  • SWOT
• 15.5 ALA Scientific Instruments Inc.
  • ALA Scientific Instruments Inc. - Overview
  • ALA Scientific Instruments Inc. - Product / Service
  • ALA Scientific Instruments Inc. - Key offerings
  • SWOT
• 15.6 Bridge to Life Ltd.
  • Bridge to Life Ltd. - Overview
  • Bridge to Life Ltd. - Product / Service
  • Bridge to Life Ltd. - Key offerings
  • SWOT
• 15.7 emka TECHNOLOGIES
  • emka TECHNOLOGIES - Overview
  • emka TECHNOLOGIES - Product / Service
  • emka TECHNOLOGIES - Key offerings
  • SWOT
• 15.8 Hugo Sachs Elektronik GmbH
  • Hugo Sachs Elektronik GmbH - Overview
  • Hugo Sachs Elektronik GmbH - Product / Service
  • Hugo Sachs Elektronik GmbH - Key offerings
  • SWOT
• 15.9 MDE GmbH
  • MDE GmbH - Overview
  • MDE GmbH - Product / Service
  • MDE GmbH - Key offerings
  • SWOT
• 15.10 OrganOx Ltd.
  • OrganOx Ltd. - Overview
  • OrganOx Ltd. - Product / Service
  • OrganOx Ltd. - Key offerings
  • SWOT
• 15.11 TransMedics Inc.
  • TransMedics Inc. - Overview
  • TransMedics Inc. - Product / Service
  • TransMedics Inc. - Key offerings
  • SWOT
• 15.12 World Precision Instruments
  • World Precision Instruments - Overview
  • World Precision Instruments - Product / Service
  • World Precision Instruments - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations